MLchartDataset catalogue

indium In 111-ABD147

Term · Oncology and biomedicine · MLC-T-ONC-014425

A radioimmunoconjugate consisting of ABD147, an antibody fragment directed against the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) conjugated to the radioisotope indium In 111 (111In), with potential imaging activity. Upon administration of indium In 111-ABD147, ABD147 targets and binds to DLL3 on DLL3-expressing tumor cells. Upon uptake and imaging, DLL3-expressing tumor cells can be visualized. This allows the assessment of DLL3 expression on tumor cells as well as tumor uptake of the agent. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.

Table 1. Record
IdentifierMLC-T-ONC-014425
FieldOncology and biomedicine
Synonyms111In-ABD147
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014425",
  "term": "indium In 111-ABD147",
  "field": "Oncology and biomedicine",
  "definition": "A radioimmunoconjugate consisting of ABD147, an antibody fragment directed against the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) conjugated to the radioisotope indium In 111 (111In), with potential imaging activity. Upon administration of indium In 111-ABD147, ABD147 targets and binds to DLL3 on DLL3-expressing tumor cells. Upon uptake and imaging, DLL3-expressing tumor cells can be visualized. This allows the assessment of DLL3 expression on tumor cells as well as tumor uptake of the agent. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.",
  "synonyms": [
    "111In-ABD147"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/indium-in-111-abd147/"
}

Record 9,195 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.